Pacemakers Market Demand is Boosted by Rising Prevalence of Cardiovascular Diseases (CVD)

Pacemakers Industry Overview

The global pacemakers market size was valued at USD 4.4 billion in 2021 and is estimated to expand at a compound annual growth rate (CAGR) of 3.4% from 2022 to 2030. Rising incidences of CVDs, increasing cost of cardiac disease management, favorable government policies, and the launch of technologically advanced pacemakers such as the MRI safe pacemakers and leadless pacemakers are chiefly driving the growth in the market. The rising burden of cardiovascular diseases is one of the key factors for the growth of the market. Coronary heart disorder is one of the primary reasons for CVD deaths globally. The economic burden of these diseases is anticipated to be more than USD 1,044 billion by 2030, which highlights the great need for cardiac pacing devices.

U.S. pacemakers market size, by application, 2020 - 2030 (USD Billion)

The novel coronavirus had severely affected patients suffering from cardiovascular disease. The spread of COVID-19 had triggered a humongous economic impact on the healthcare and medical device industry. As per the American Heart Association, Circulation Journal, 2020, so far COVID-19 had affected 185 countries and more than 30,00,000 patients globally. Among patients with COVID-19, there is a high prevalence of CVD. Increasing demand to improve patient outcomes for various pacemaker implantations, with improved and minimally invasive procedures is the key factor driving the growth of the pacemaker market. Moreover, favorable reimbursement procedures, such as the Medicare system in the U.S. and NHS in the U.K. are among the key factors boosting the market.

Gather more insights about the market drivers, restraints, and growth of the Global Pacemakers market

Medical device companies such as Boston Scientific Corporation and Medtronic are now offering new products that are covered under reimbursement packages, which benefit patients. Furthermore, organizations are more fixated on manufacturing high-end pacemakers catering to customized care. These innovations are enhancing accuracy, providing additional capabilities to enhance the workflow, and facilitating error reduction. For instance, in May 2020, the home monitoring system by BIOTRONIK offered a cost-effective and safe remote management of pacemaker patients at the Large Multi-Center Study. This is a significant move for routine remote follow-ups amidst COVID-19.

Browse through Grand View Research's Medical Devices Industry Research Reports.

Cardiac Rhythm Management Devices Market - The global cardiac rhythm management devices market size was valued at USD 18.1 billion in 2021 and is estimated to expand at a compound annual growth rate (CAGR) of 6.5% from 2022 to 2030.

Arrhythmia Monitoring Devices Market - The global arrhythmia monitoring devices market size was valued at USD 4.98 billion in 2017. It is projected to expand at a CAGR of 6.8% during the forecast period.

Pacemakers Market Segmentation 

Grand View Research has segmented the global pacemakers market on the basis of product, type, application, end-use, and region:

Pacemakers Product Outlook (Revenue, USD Million, 2017 - 2030)

  • Implantable pacemakers
  • External pacemakers

Pacemakers Type Outlook (Revenue, USD Million, 2017 - 2030)

  • MRI Compatible Pacemakers
  • Conventional Pacemakers

Pacemakers Application Outlook (Revenue, USD Million, 2017 - 2030)

  • Arrhythmias
  • Congestive Heart Failure
  • Others

Pacemakers End-use (Revenue, USD Million, 2017 - 2030)

  • Hospitals & Cardiac Centers
  • Ambulatory Surgical Centers
  • Others

Pacemakers Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa (MEA)

Market Share Insights

June 2021: Medtronic launched the Micra AV, a self-contained, miniaturized pacemaker for delivering advanced pacing technology for atrioventricular (AV) block patients through a minimally invasive approach.

Key Companies profiled:

Some of the prominent players in the Pacemakers market include:

  • OSYPKA MEDICAL 
  • Boston Scientific Corporation
  • Zoll Medical Corporation, an Asahi Kasei Group Company
  • Medtronic
  • BIOTRONIK SE & Co. KG
  • MicroPort Scientific Corporation
  • MEDICO S.R.L.
  • Shree Pacetronix Ltd.
  • Abbott
  • OSCOR Inc
  • Lepu Medical Technology(Beijing)Co.,Ltd.

Order a free sample PDF of the Pacemakers Market Intelligence Study, published by Grand View Research.

No comments:

Post a Comment

Analyzing the Impact of Corn Procurement on Revenue: A Forecasting Perspective

The Corn Category is expected to grow at a 3.1% CAGR from 2023 to 2030. The key factors driving corn demand are the rising demand for proce...